openPR Logo
Press release

Creative Biolabs Shines a Light on Hepatocellular Cancer Research

03-26-2024 07:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: PRChoices
Creative Biolabs Shines a Light on Hepatocellular Cancer

Creative Biolabs introduces innovative hepatocellular cancer solutions out of autoimmunity and ribosomal outlooks.
New York, USA - March 26, 2024 - Hepatocellular carcinoma (HCC) is a malignant neoplasm that is seeing a global rise in prevalence and poses a significant risk to human well-being. It is distinguished by elevated levels of metastasis, recurrence, and death. In the relentless battle against this type of primary liver cancer, Creative Biolabs offers exemplary services in research, diagnostic, and therapeutic development and proudly introduces a full set of HCC-centered solutions.

Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg

One of the pioneering avenues pursued by Creative Biolabs is the exploration of the intricate relationship between ribosomes and hepatocellular cancer-to uncover rRNA transcription and ribosomal protein activities behind the occurrence of HCC in order to facilitate early detection and targeted treatment.

"As has been reflected in the latest research reports, ribosomes play a part in HCC development," according to a scientist at Creative Biolabs, "which represent critical diagnostic and therapeutic possibilities. We at Creative Biolabs have developed a powerful Ribosome and Hepatocellular Cancer [https://ribosome.creative-biolabs.com/hepatocellular-cancer.htm] platform that facilitates any projects needing ribosomal transcriptome or ribosomal proteomics analysis, thus defining ribosome properties and functions precisely and efficiently."

Creative Biolabs also sheds light on the significance of natural autoantibodies (NAAs) in the context of hepatocellular cancer, recognizing the diagnostic potential inherent in specific molecular interactions, and developing a full set of NAA assays to arm the projects with any critical factors involved in HCC and other NAA associated primary liver cancers [https://www.creative-biolabs.com/natural-autoantibody/primary-liver-cancer.htm], such as nucleophosmin 1, cytokeratin 8, CENPT, and DNA topoisomerase II.

* NAA Detection

* NAA Profiling

* NAA Affinity Measurement

* NAA Epitope Mapping

* NAA Paratope Mapping

"By elucidating the intricate landscape of NAA-mediated HCC, our NAA detection and profiling present an alternative to various diseases with advantages of minimalist hardware, short time-frames, and an abundance of targets to decipher the intricate mechanisms and provide data-based insights into disease etiology and progression, thereby facilitating the development of innovative diagnostic modalities and precision therapies and heralding a new era in liver cancer management." Summarized the scientist.

Learn more about Creative Biolabs ribosome and NAA solutions at https://ribosome.creative-biolabs.com and https://www.creative-biolabs.com/natural-autoantibody.

About

Creative Biolabs is a leading biotechnology company dedicated to advancing scientific understanding and fostering innovation in the field of liver cancer research, diagnosis, and therapy development. With a team of renowned experts and cutting-edge technologies, Creative Biolabs remains at the forefront of the fight against liver cancer, offering unrivaled expertise and support to researchers and pharmaceutical partners worldwide.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-shines-a-light-on-hepatocellular-cancer-research]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Creative Biolabs Shines a Light on Hepatocellular Cancer Research here

News-ID: 3443011 • Views:

More Releases from Getnews

JinIX Opens Registration for Rare Disease Clinical Datathon Connecting Patients With Medical Experts
08-24-2026 | Health & Medicine
Getnews
JinIX Opens Registration for Rare Disease Clinical Datathon Connecting Patients …
Image: https://www.globalnewslines.com/uploads/2026/08/1787565354.jpg The JinIX Clinical Datathon is an online event that connects people living with rare diseases with verified physicians, researchers and medical specialists who analyze consented patient data using JinIX's AI Health Navigator. The program offers a $1,000 prize pool across four medical expert winners and SAN FRANCISCO, United States - Aug 24, 2026 - JinIX [https://www.jinix.com/] has announced registration for its Rare Disease Clinical Datathon [https://www.jinix.com/datathon], a patient-centered clinical analysis
Supporting the Next Generation of Life Science Researchers: Creative Biolabs 2026 Scholarship Program
Supporting the Next Generation of Life Science Researchers: Creative Biolabs 202 …
Biotechnology can invest in better platforms, instruments, and automation, but it cannot automate the development of scientific judgment. Creative Biolabs' 2026 Scholarship Program places that human challenge at the center, offering a $1,000 award while encouraging students to practice scientific writing, critical thinking, and problem-solving around emerging life science questions. New York, USA - August 24, 2026 - The biotechnology industry often talks about innovation in terms of new modalities, faster
Optimizing Antibody Biotinylation: Balancing Labeling Efficiency and Biological Activity
Optimizing Antibody Biotinylation: Balancing Labeling Efficiency and Biological …
Creative Biolabs is highlighting why antibody biotinylation optimization should focus on functional performance rather than maximum label incorporation. New York, USA - August 24, 2026 - In flow cytometry and related immunoassay workflows, reagent-to-protein molar excess, buffer chemistry, NHS-ester hydrolysis, purification, degree of labeling (DOL), and post-conjugation activity can all influence signal-to-background ratio and reproducibility. Image: https://www.globalnewslines.com/uploads/2026/05/3a75e3371c2852e442807ca390c097e0.jpg Why Labeling Density Is Not the Same as Assay Performance The biotin-streptavidin system remains a versatile tool
A Portfolio of 19 Automotive MOSFETs Debuts: the World's First 12-Inch Mass Production Cuts Per-Chip Cost by Up to 50%
A Portfolio of 19 Automotive MOSFETs Debuts: the World's First 12-Inch Mass Prod …
Shanghai, China - August 24, 2026 - Power MOSFETs are the heart of every electrical device - home appliances, industrial motors, new energy vehicle electronic controls, AI data center power supplies. The new-generation T2X technology platform optimizes gate structure, doping profile, and termination design to sharply reduce on-resistance at the same chip area, while also improving dynamic parameters such as gate charge and gate-drain charge. The result is a simultaneous

All 5 Releases


More Releases for Creative

GPCR Screening Service Market Industry Dynamics and Contributions by Profacgen, …
The GPCR (G-Protein Coupled Receptor) Screening Service Market is at the forefront of biopharmaceutical research and drug discovery. GPCRs are pivotal in numerous physiological processes, making them prime targets for therapeutic intervention. As the scientific community continues to unravel the complexities of GPCRs, the demand for specialized screening services is surging. The market encompasses a wide range of applications, including drug development, diagnostics, and therapeutic interventions, thereby broadening its relevance. Recent
Creative Biolabs: Creative Thoughts to Shake Up the mRNA R&D
Creative Biolabs offers top-notch mRNA technology support to fuel emerging therapeutic discoveries. New York, USA - July 16, 2024 - Recent headlines have been dominated by the transformative potential of mRNA-based therapies, extending beyond infectious diseases to encompass cancer, genetic disorders, and autoimmune conditions. This surge in interest underscores the importance of reliable and innovative partners in mRNA research and development. Creative Biolabs stands out as a pivotal player, providing comprehensive
Creative Biolabs: Creative Thoughts to Shake Up mRNA R&D
Creative Biolabs offers top-notch mRNA technology support to fuel emerging therapeutic discoveries. New York, USA - July 2, 2024 - Recent headlines have been dominated by the transformative potential of mRNA-based therapies, extending beyond infectious diseases to encompass cancer, genetic disorders, and autoimmune conditions. This surge in interest underscores the importance of reliable and innovative partners in mRNA research and development. Creative Biolabs stands out as a pivotal player, providing comprehensive
Art Eeets Business: Creative Workspaces, Creative Working With AltF Coworking Ok …
AltF Coworking in Okhla redefines the work life for working professionals by creating a supreme work experience where elevating, luxurious, and professional workspaces attract the attention of employees and owners who wish for a change in their work lives. With the launch of the latest property of AltF Coworking in Okhla, the work life of corporate professionals has been transformed to a large extent. [NEW DELHI, 21st December 2023] -
creative@allstatescorp.com
To safeguard, enhance, and advance men's prostate health, prostadine was created. This natural treatment is superior to many other prostate supplements since it deals with the root causes of the condition. Prostadine Reviews from Actual Users Anxiety levels are rising as a result of our modern culture's increased reliance on technology and media. We are unable to give our health the care it deserves due to the pressures of modern living. Therefore,
Membrane Protein Characterization Service Market 2018-2028 by Key Prominent Play …
Membrane Protein Characterization Service Market Insights Membrane protein characterization at atomic resolution is always a big challenge in development of membrane protein-based antibody as well as small molecule drugs. The development of these membrane protein related antibodies and vaccines require high resolution structural information of target protein. Thus membrane protein characterization plays a vital role in drug discovery, propelling the demand for membrane protein characterization Service across the world. In order